{
  "id": "62211b5a3a8413c65300006b",
  "type": "summary",
  "question": "Summarize Fanconi's anemia",
  "ideal_answer": "Fanconi anemia (FA) is a rare autosomal or X-linked genetic disorder characterized by chromosomal breakages, congenital abnormalities, bone marrow failure (BMF), and cancer.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/7240694",
    "http://www.ncbi.nlm.nih.gov/pubmed/12053693",
    "http://www.ncbi.nlm.nih.gov/pubmed/1574115",
    "http://www.ncbi.nlm.nih.gov/pubmed/25332625",
    "http://www.ncbi.nlm.nih.gov/pubmed/1530123",
    "http://www.ncbi.nlm.nih.gov/pubmed/12483114",
    "http://www.ncbi.nlm.nih.gov/pubmed/34735020",
    "http://www.ncbi.nlm.nih.gov/pubmed/33977503",
    "http://www.ncbi.nlm.nih.gov/pubmed/31281162",
    "http://www.ncbi.nlm.nih.gov/pubmed/31390058",
    "http://www.ncbi.nlm.nih.gov/pubmed/11524917",
    "http://www.ncbi.nlm.nih.gov/pubmed/21331524",
    "http://www.ncbi.nlm.nih.gov/pubmed/16188650",
    "http://www.ncbi.nlm.nih.gov/pubmed/11759873",
    "http://www.ncbi.nlm.nih.gov/pubmed/15643609",
    "http://www.ncbi.nlm.nih.gov/pubmed/28657246",
    "http://www.ncbi.nlm.nih.gov/pubmed/19427003",
    "http://www.ncbi.nlm.nih.gov/pubmed/19728769",
    "http://www.ncbi.nlm.nih.gov/pubmed/34585473"
  ],
  "snippets": [
    {
      "text": "Fanconi anemia (FA) is a rare autosomal or X-linked genetic disorder characterized by chromosomal breakages, congenital abnormalities, bone marrow failure (BMF), and cancer. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34585473",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a multisystem disease, characterized by the triad of physical abnormalities, bone marrow failure, and increased risk for malignancy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33977503",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a rare disorder resulting from defects in genes responsible for DNA damage responses. It is characterized by congenital anomalies, aplastic anemia, and a predisposition to cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34735020",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a rare inherited genetic condition that may lead to bone marrow failure, leukemia, and/or solid tumors. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31390058",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi's Anaemia is a rare autosomal recessive disease for which the incidence of head and neck cancer can be increased 700-fold1. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28657246",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi's Anemia is primarily an autosomal recessive genetic disorder characterized by congenital abnormalities, defective haematopoiesis leading to bone marrow failure and increased risk of development of Myelodysplastic syndrome, acute myeloid leukemia and solid tumours",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25332625",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi's anemia is a rare autosomal recessive disorder associated with variable clinical manifestations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12053693",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi's anemia, an inherited disorder characterized by bone marrow aplasia, peripheral pancytopenia, and multiple congenital defects, has a association with certain types of malignancies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7240694",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a rare inherited disease characterized by congenital anomalies, growth retardation, aplastic anemia and an increased risk of acute myeloid leukemia and squamous cell carcinomas.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19427003",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a genetically heterogeneous disorder associated with chromosome instability and a highly elevated risk for developing cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19728769",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia proteins are extensively connected with DNA caretaker proteins, and appear to function as a hub for the coordination of DNA repair with DNA replication and cell cycle progression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19728769",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi's anaemia is a rare autosomal recessive disorder characterized by progressive pancytopaenia and a cellular hypersensitivity to DNA crosslinking agents.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1574115",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi's anemia is an autosomal recessive disorder with a high incidence (greater than 90%) of aplastic anemia and a premalignant component with a greater than 10% risk of leukemia or solid tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1530123",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Fanconi's anemia is an autosomal recessive disease associated with chromosomal breakage as well as pancytopenia, skin pigmentation, renal hypoplasia, cardiac defects, microcephaly, congenital malformations of the skeleton, hypogonadism, and increased risk ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11759873",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi's anemia is a rare autosomal recessive disease characterized by congenital abnormalities, a progressive pancytopenia and a predisposition to cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11524917",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is an autosomal recessive chromosomal instability disorder, characterized by congenital anomalies, defective hematopoiesis and a high risk of developing acute myeloid leukemia and certain solid tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16188650",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is a cancer predisposition disorder characterized by progressive bone marrow failure, congenital developmental defects, chromosomal abnormalities, and cellular hypersensitivity to DNA interstrand crosslink (ICL) agents.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21331524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is an inherited bone marrow failure syndrome characterized by multiple congenital abnormalities, progressive bone marrow failure, and a predisposition to malignancies, resulting from mutations in one of the 22 known FANC genes (from FANCA to FANCW).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31281162",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia (FA) is an autosomal recessive disorder that is defined by cellular hypersensitivity to DNA cross-linking agents, and is characterized clinically by developmental abnormalities, progressive bone-marrow failure, and predisposition to leukemia and solid tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15643609",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fanconi anemia is a rare autosomal recessive disease characterized by bone marrow failure, developmental anomalies, a high incidence of myelodysplasia and acute nonlymphocytic leukemia, and cellular hypersensitivity to cross linking agents.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12483114",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}